Neoplasms by Histologic Type  >>  Ogsiveo (nirogacestat)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ogsiveo (nirogacestat) / SpringWorks Therap
NCT02109445: Study Of PF-03084014 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Metastatic Pancreatic Adenocarcinoma Not Previously Treated With Anticancer Therapies

Terminated
2
3
US
PF-03084014, Gemcitabine, Nab-paclitaxel, Abraxane
Pfizer, Academic GI Cancer Consortium (AGICC)
Metastatic Cancer Pancreas
11/14
11/14

Download Options